Editorial
World J Exp Med
3(4):50-55.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.50
Abstract (1350)
|
Core Tip (1253)
|
Full Article (HTML) (4086)
|
Figures (1-1) (108)
|
Full Article (PDF)-1868K (485)
|
Peer-Review Report-76K (266)
|
Answering Reviewers-79K (330)
|
Received: 06/28/2013
|
Revised: 09/06/2013
|
Accepted: 11/08/2013
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (10501)
|
Similar Articles (289)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Exp Med
3(4):56-61.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.56
Abstract (1456)
|
Core Tip (1498)
|
Full Article (HTML) (7305)
|
Figures (1-1) (111)
|
Tables (1-1) (102)
|
Full Article (PDF)-2122K (650)
|
Peer-Review Report-138K (337)
|
Answering Reviewers-378K (380)
|
Received: 06/28/2013
|
Revised: 09/16/2013
|
Accepted: 11/03/2013
|
CrossRef
|
Google Scholar
|
Times Cited (10)
|
Total Visits (14417)
|
Similar Articles (201)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
World J Exp Med
3(4):62-73.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.62
Abstract (1047)
|
Core Tip (979)
|
Full Article (HTML) (3165)
|
Full Article (PDF)-2198K (313)
|
Peer-Review Report-77K (192)
|
Answering Reviewers-70K (148)
|
Received: 07/30/2013
|
Revised: 09/27/2013
|
Accepted: 11/05/2013
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7954)
|
Similar Articles (21)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Exp Med
3(4):74-86.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.74
Abstract (1642)
|
Core Tip (1489)
|
Full Article (HTML) (6437)
|
Figures (1-1) (109)
|
Full Article (PDF)-3670K (524)
|
Peer-Review Report-107K (255)
|
Answering Reviewers-72K (189)
|
Received: 06/28/2013
|
Revised: 09/06/2013
|
Accepted: 11/03/2013
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (12866)
|
Similar Articles (3)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Exp Med
3(4):87-99.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.87
Abstract (1256)
|
Core Tip (1127)
|
Full Article (HTML) (4344)
|
Figures (1-2) (93)
|
Tables (1-2) (92)
|
Full Article (PDF)-4074K (474)
|
Peer-Review Report-85K (219)
|
Answering Reviewers-352K (193)
|
Received: 05/29/2013
|
Accepted: 10/16/2013
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (9317)
|
Similar Articles (0)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Original Article
Epigallocatechin-3-gallate suppresses transforming growth factor-beta signaling by interacting with the transforming growth factor-beta type II receptor
![](https://www.f6publishing.com/contents/images/coretip.png)
World J Exp Med
3(4):100-107.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.100
Abstract (1746)
|
Core Tip (1315)
|
Full Article (HTML) (5772)
|
Figures (1-5) (147)
|
Full Article (PDF)-1926K (454)
|
Peer-Review Report-206K (295)
|
Answering Reviewers-219K (383)
|
Received: 05/14/2013
|
Revised: 07/12/2013
|
Accepted: 09/18/2013
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (12416)
|
Similar Articles (4)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open